Research

Medical Sciences

Title :

A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients

Area of research :

Medical Sciences

Focus area :

Task Force (TF)

Principal Investigator :

Ms. N. Wadhwa, Associate Professor, Translational Health Science & Technology Institute, Haryana

Timeline Start Year :

2019

Timeline End Year :

2023

Details

Total Budget (INR):

 89,15,650

Organizations involved

Implementing Agency :

 Translational Health Science & Technology Institute, Haryana

Funding Agency :

 Indian Council of Medical Research
(ICMR)

Source :

Extramural R&D Projects listed in NSTMIS database 2019-20

Related Research

10-Minute paper-based test kit to detect Sars-Cov-2
A learning health system for adherence to secondary prevention in cardiovascular disease in Kerala using informatics and non-physician health workers: a 1-year prospective study
A mutlicentric study on Systemic Lupus Erythematosus (SLE) from the north eastern region of India- Early diagnosis to research potential for understanding disease pathogenesis
A randomized, Double-blind, Placebo and Active controlled, Multicenter, Phase 3 Study to Access the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely Active Rheumatoid Arthritis who Are Naive to MTX Therapy
An interventional single arm study to observe & assess the effectiveness of Vyaghradi Kashaya Tab in preventing the progression of severity in asymptomatic, mild to moderate Covid-19 cases